• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-1 家族细胞因子在阿尔茨海默病发病机制和治疗中的作用。

The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer's disease.

机构信息

Department of Laboratory Medicine, Chengdu Eighth People's Hospital (Geriatric Hospital of Chengdu Medical College), Chengdu, 610000, Sichuan, China.

Urology Department, Huili People's Hospital, Huili615100, Guangyuan, Sichuan, China.

出版信息

Inflammopharmacology. 2024 Oct;32(5):2681-2694. doi: 10.1007/s10787-024-01534-8. Epub 2024 Aug 10.

DOI:10.1007/s10787-024-01534-8
PMID:39126573
Abstract

Alzheimer's disease (AD) is a progressive and irreversible neurological condition that occurs with age and poses a significant global public health concern, is distinguished by the degeneration of neurons and synapses in various regions of the brain. While the exact processes behind the neurodegeneration in AD are not completely known, it is now acknowledged that inflammation may have a significant impact on the beginning and advancement of AD neurodegeneration. The severity of many neurological illnesses can be influenced by the equilibrium between pro-inflammatory and anti-inflammatory mediators. The IL-1 family of cytokines is linked to innate immune responses, which are present in both acute inflammation and chronic inflammatory diseases. Research on the role of the IL-1 family in chronic neurological disease has been concentrated on AD. In this context, there is indirect evidence suggesting its involvement in the development of the disease. This review aims to provide a summary of the contribution of every IL-1 family member in AD pathogenesis, current immunotherapies in AD disease, and present treatment possibilities for either targeting or boosting these cytokines.

摘要

阿尔茨海默病(AD)是一种随着年龄增长而发生的进行性和不可逆转的神经疾病,是一个重大的全球公共卫生关注点,其特征是大脑各个区域的神经元和突触退化。虽然 AD 中神经退行性变的确切过程尚不完全清楚,但现在已经认识到炎症可能对 AD 神经退行性变的开始和进展有重大影响。许多神经疾病的严重程度可以受到促炎和抗炎介质之间的平衡的影响。白细胞介素-1 家族细胞因子与先天免疫反应有关,先天免疫反应存在于急性炎症和慢性炎症性疾病中。关于白细胞介素-1 家族在慢性神经疾病中的作用的研究主要集中在 AD 上。在这种情况下,有间接证据表明其参与了疾病的发展。本综述旨在总结白细胞介素-1 家族每个成员在 AD 发病机制中的作用、AD 疾病中的当前免疫疗法,以及针对或增强这些细胞因子的现有治疗可能性。

相似文献

1
The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer's disease.白细胞介素-1 家族细胞因子在阿尔茨海默病发病机制和治疗中的作用。
Inflammopharmacology. 2024 Oct;32(5):2681-2694. doi: 10.1007/s10787-024-01534-8. Epub 2024 Aug 10.
2
New therapeutic targeting of Alzheimer's disease with the potential use of proline-rich polypeptide complex to modulate an innate immune response - preliminary study.新型阿尔茨海默病治疗靶点——富含脯氨酸多肽复合物调节固有免疫反应的初步研究。
J Neuroinflammation. 2019 Jul 5;16(1):137. doi: 10.1186/s12974-019-1520-6.
3
Roles of Cytokines in Alzheimer's Disease.细胞因子在阿尔茨海默病中的作用。
Int J Mol Sci. 2024 May 26;25(11):5803. doi: 10.3390/ijms25115803.
4
Inflammation of the brain in Alzheimer's disease: implications for therapy.阿尔茨海默病中的脑部炎症:对治疗的启示
J Leukoc Biol. 1999 Apr;65(4):409-15. doi: 10.1002/jlb.65.4.409.
5
Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration.慢性 IL-1β 介导的神经炎症减轻了阿尔茨海默病小鼠模型中的淀粉样蛋白病理,而没有引起明显的神经退行性变。
J Neuroimmune Pharmacol. 2012 Mar;7(1):156-64. doi: 10.1007/s11481-011-9331-2. Epub 2011 Dec 16.
6
Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.炎症细胞因子与阿尔茨海默病:基于基因多态性视角的综述
Neurosci Bull. 2016 Oct;32(5):469-80. doi: 10.1007/s12264-016-0055-4. Epub 2016 Aug 27.
7
Innate Immunity Fights Alzheimer's Disease.先天免疫对抗阿尔茨海默病。
Trends Neurosci. 2015 Nov;38(11):674-681. doi: 10.1016/j.tins.2015.08.008.
8
The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence.先天免疫在迟发性阿尔茨海默病发病机制中的早期作用:神经病理学、流行病学和遗传学证据。
Curr Alzheimer Res. 2011 Mar;8(2):142-50. doi: 10.2174/156720511795256080.
9
A review: inflammatory process in Alzheimer's disease, role of cytokines.综述:阿尔茨海默病中的炎症过程,细胞因子的作用。
ScientificWorldJournal. 2012;2012:756357. doi: 10.1100/2012/756357. Epub 2012 Apr 1.
10
Impact of IL-21-associated peripheral and brain crosstalk on the Alzheimer's disease neuropathology.IL-21 相关的外周与脑内串扰对阿尔茨海默病神经病理学的影响。
Cell Mol Life Sci. 2022 Jun 1;79(6):331. doi: 10.1007/s00018-022-04347-6.

本文引用的文献

1
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's disease.IL1RL1 基因变异可降低可溶性 ST2 水平,并降低载脂蛋白 E-ε4 在女性阿尔茨海默病患者中的风险效应。
Nat Aging. 2022 Jul;2(7):616-634. doi: 10.1038/s43587-022-00241-9. Epub 2022 Jul 15.
2
Immunotherapies for Alzheimer's Disease-A Review.阿尔茨海默病的免疫疗法——综述
Vaccines (Basel). 2022 Sep 14;10(9):1527. doi: 10.3390/vaccines10091527.
3
IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer's disease mouse model.
IL-37 的表达减少了阿尔茨海默病小鼠模型中的急性和慢性神经炎症,并挽救了认知障碍。
Elife. 2022 Aug 30;11:e75889. doi: 10.7554/eLife.75889.
4
Mitophagy in Alzheimer's disease: Molecular defects and therapeutic approaches.阿尔茨海默病中的自噬:分子缺陷与治疗方法。
Mol Psychiatry. 2023 Jan;28(1):202-216. doi: 10.1038/s41380-022-01631-6. Epub 2022 Jun 3.
5
Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.小胶质细胞在阿尔茨海默病神经炎症发病机制中的作用及相关治疗靶点
Front Immunol. 2022 Apr 26;13:856376. doi: 10.3389/fimmu.2022.856376. eCollection 2022.
6
IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment.同型半胱氨酸治疗后,MCI 患者血清白介素-33 和白介素-10 水平升高。
Front Immunol. 2022 Apr 19;13:813951. doi: 10.3389/fimmu.2022.813951. eCollection 2022.
7
A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.一种靶向 NLRP3 炎性小体的新型抑制剂可减少阿尔茨海默病转基因小鼠的神经病理学并改善认知功能。
J Alzheimers Dis. 2021;82(4):1769-1783. doi: 10.3233/JAD-210400.
8
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy.针对疾病中的氧化应激:抗氧化治疗的前景和局限性。
Nat Rev Drug Discov. 2021 Sep;20(9):689-709. doi: 10.1038/s41573-021-00233-1. Epub 2021 Jun 30.
9
Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL-1β drives amplified responses in primed astrocytes and neuronal network dysfunction.急性全身炎症加重阿尔茨海默病的神经炎症:IL-1β 驱动敏化星形胶质细胞和神经元网络功能障碍的放大反应。
Alzheimers Dement. 2021 Oct;17(10):1735-1755. doi: 10.1002/alz.12341. Epub 2021 Jun 3.
10
Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.白细胞介素-33 在中枢神经系统中的治疗机会。
Front Immunol. 2021 May 17;12:654626. doi: 10.3389/fimmu.2021.654626. eCollection 2021.